tm logo
CURASEN
Live/Pending
SU - NON-FINAL ACTION - MAILED

non

on 01 Apr 2024

Last Applicant/ Owned by

733 Industrial Road

San Carlos

CA

94070

Serial Number

90075978 filed on 27th Jul 2020

Registration Number

N/A

Correspondent Address

Susan N. Acquista, Esq.

DLA PIPER LLP (US)

555 Mission Street, Suite 2400

San Francisco, CA 94105

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CURASEN

Scientific research for medical purposes in the areas of neurological, immunological, cardiovascular, respiratory, and orphan diseases, excluding dermatological, dental, orthopedic and blood-based diseases Pharmaceutical products for the prevention, treatment and diagnosis of neurological diseases, namely, Parkinson's disease

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific research for medical purposes in the areas of neurological, immunological, cardiovascular, respiratory, and orphan diseases, excluding dermatological, dental, orthopedic and blood-based diseases


First Use Date in General

31st Dec 2018

First Use Date in Commerce

31st Oct 2021

Class [005]
Pharmaceutical Products


Pharmaceutical products for the prevention, treatment and diagnosis of neurological diseases, namely, Parkinson's disease


First Use Date in General

31st Dec 2018

First Use Date in Commerce

31st Oct 2021

Mark Details


Serial Number

No 90075978

Mark Type

No Service Mark

Attorney Docket Number

No 425034900104

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Apr 2024STATEMENT OF USE PROCESSING COMPLETE
01st Apr 2024SU - NON-FINAL ACTION - WRITTEN
01st Apr 2024NON-FINAL ACTION E-MAILED
01st Apr 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
30th Mar 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Mar 2024SOU TEAS EXTENSION RECEIVED
29th Mar 2024SOU EXTENSION 5 FILED
29th Mar 2024SOU EXTENSION 5 GRANTED
29th Mar 2024TEAS STATEMENT OF USE RECEIVED
29th Mar 2024USE AMENDMENT FILED